ALPHAHELIX MOL.DIAGN. SK1 Market Cap ($839.64K)
Market Cap & Net Worth: ALPHAHELIX MOL.DIAGN. SK1 (4MB)
ALPHAHELIX MOL.DIAGN. SK1 market cap. ALPHAHELIX MOL.DIAGN. SK1 (F:4MB) has a market capitalization of $839.64K (€718.19K) as of November 3, 2026. Listed on the F stock exchange, this Germany-based company holds position #30790 globally and #2692 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ALPHAHELIX MOL.DIAGN. SK1's stock price €0.01 by its total outstanding shares 68398899 (68.40 Million). Also see how efficiently does ALPHAHELIX MOL.DIAGN. SK1 generate cash for how efficiently the company converts equity into cash flow.
ALPHAHELIX MOL.DIAGN. SK1 Market Cap History (2021–2026)
ALPHAHELIX MOL.DIAGN. SK1 market cap history from 2021 to 2026. Data shows change from $18.31 Million to $839.64K (-39.00% CAGR). Check 4MB live share price for real-time trading data and today's change.
ALPHAHELIX MOL.DIAGN. SK1 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ALPHAHELIX MOL.DIAGN. SK1's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of ALPHAHELIX MOL.DIAGN. SK1 to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.04x
ALPHAHELIX MOL.DIAGN. SK1's market cap is 0.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $3.82 Million | $34.33 Million | -$2.22 Million | 0.11x | N/A |
| 2023 | $2.59 Million | $26.10 Million | -$9.48 Million | 0.10x | N/A |
| 2024 | $1.12 Million | $25.10 Million | -$7.87 Million | 0.04x | N/A |
| 2025 | $1.40 Million | $32.36 Million | -$3.54 Million | 0.04x | N/A |
Competitor Companies of 4MB by Market Capitalization
Companies near ALPHAHELIX MOL.DIAGN. SK1 in the global market cap rankings as of November 3, 2026. Also see ALPHAHELIX MOL.DIAGN. SK1 total assets for a full breakdown of the balance sheet.
Key companies related to ALPHAHELIX MOL.DIAGN. SK1 by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #142 globally with a market cap of $164.04 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #480 globally with a market cap of $56.33 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #530 globally with a market cap of $51.40 Billion USD ( CN¥351.23 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $697.00 |
| #142 | Danaher Corporation | NYSE:DHR | $164.04 Billion | $232.23 |
| #480 | Natera Inc | NASDAQ:NTRA | $56.33 Billion | $414.30 |
| #530 | WuXi AppTec Co Ltd | SHG:603259 | $51.40 Billion | CN¥142.01 |
Market Capitalization of ALPHAHELIX MOL.DIAGN. SK1 (2021–2026)
Market capitalization of ALPHAHELIX MOL.DIAGN. SK1 from 2021 to today. Between 2021 and today, ALPHAHELIX MOL.DIAGN. SK1's market cap moved from $18.31 Million to $ 839.64K, with a yearly change of -39.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €839.64K | -40.00% |
| 2025 | €1.40 Million | +25.00% |
| 2024 | €1.12 Million | -56.79% |
| 2023 | €2.59 Million | -32.22% |
| 2022 | €3.82 Million | -79.13% |
| 2021 | €18.31 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 2nd, 2026 the market cap of ALPHAHELIX MOL.DIAGN. SK1 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $839.64K USD |
| MoneyControl | $839.64K USD |
| MarketWatch | $839.64K USD |
| marketcap.company | $839.64K USD |
| Reuters | $839.64K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ALPHAHELIX MOL.DIAGN. SK1
Level Bio AB (publ) manufactures and distributes cutting-edge solutions in the Nordic region and internationally. It develops and manufactures diagnostic kits for the clinical market, as well as act as a distributor and full service partner to molecular biology labs in the Nordics. The company was formerly known as AlphaHelix Molecular Diagnostics AB (publ) and changed its name to Level Bio AB (p… Read more